Retinal Vein Occlusion - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Retinal Vein Occlusion -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Retinal Vein Occlusion in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Retinal Vein Occlusion. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Retinal Vein Occlusion. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Retinal Vein Occlusion sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Retinal Vein Occlusion market.

  • Identifying prevalent patient populations as well as risk factors in the global Retinal Vein Occlusion market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Retinal Vein Occlusion therapeutics in each of the markets covered.

Retinal Vein Occlusion - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Retinal Vein Occlusion Overview
Retinal Vein Occlusion Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Retinal Vein Occlusion

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Retinal Vein Occlusion
Sex-Specific Prevalent/Incident Cases of Retinal Vein Occlusion
Disease Type Specific Prevalent/Incident Cases of Retinal Vein Occlusion

8.Prevalent & Incident Cases by 7 MM-2015-2025
Retinal Vein Occlusion Epidemiology of United States-2025
Retinal Vein Occlusion Epidemiology of United Kingdom-2025
Retinal Vein Occlusion Epidemiology of Germany-2025
Retinal Vein Occlusion Epidemiology of France-2025
Retinal Vein Occlusion Epidemiology of Spain-2025
Retinal Vein Occlusion Epidemiology of Italy-2025
Retinal Vein Occlusion Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Retinal Vein Occlusion Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Retinal Vein Occlusion Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Retinal Vein Occlusion Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Retinal Vein Occlusion Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Retinal Vein Occlusion Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Retinal Vein Occlusion Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Retinal Vein Occlusion Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Retinal Vein Occlusion Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Retinal Vein Occlusion Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Retinal Vein Occlusion Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Retinal Vein Occlusion Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Retinal Vein Occlusion Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Retinal Vein Occlusion Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Retinal Vein Occlusion Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Retinal Vein Occlusion Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Retinal Vein Occlusion (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Retinal Vein Occlusion By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Retinal Vein Occlusion Sub-population,Japan (2015-2025)
  • United States Contact Lens Solution Market Report 2018
    Published: 16-Jan-2018        Price: US 3800 Onwards        Pages: 112
    In this report, the United States Contact Lens Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ra......
  • Global Glaucoma Therapeutics Market Size, Status and Forecast 2025
    Published: 10-Jan-2018        Price: US 3300 Onwards        Pages: 99
    This report studies the global Glaucoma Therapeutics market, analyzes and researches the Glaucoma Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Allergan - Merck - Novartis - Pfizer - Santen Pharmaceuticals - Valeant Pharmaceuticals - Aerie Pharmaceuticals Market segment by Regions/Countries, this report covers......
  • Asia-Pacific Ophthalmology Amniotic Membrane Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 03-Jan-2018        Price: US 4480 Onwards        Pages: 116
    Amniotic membrane (AM) can function in the eye as a basement membrane substitute or as a temporary graft. It has anti-inflammatory and anti-scarring effects and contains growth factors that promote epithelial wound healing on the surface of the eye. Scope of the Report: This report focuses on the Ophthalmology Amniotic Membrane in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on ......
  • Global Eye Drops & Lubricants Market Professional Survey Report 2017
    Published: 03-Jan-2018        Price: US 3500 Onwards        Pages: 100
    This report studies Eye Drops & Lubricants in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bausch + Lomb - Abbott - Clear Eyes - Sager Pharma - A......
  • Global Eye Drops & Lubricants Market Professional Survey Report 2018
    Published: 01-Jan-2018        Price: US 3500 Onwards        Pages: 100
    This report studies Eye Drops & Lubricants in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bausch + Lomb - Abbott - Clear Eyes - Sager Pharma - A......
  • Graves' Ophthalmopathy - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 33
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy - Pipeline Review, H2 2017, provides an overview of the Graves' Ophthalmopathy (Ophthalmology) pipeline landscape. Graves' ophthalmopathy is an autoimmune condition where the thyroid gland mistakenly senses harmful cells and releases antibodies to combat them. Since there are no harmful cells, the released antibodies end up fusing with muscles in the eyes, causing the onset o......
  • Age Related Macular Degeneration - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 537
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration - Pipeline Review, H2 2017, provides an overview of the Age Related Macular Degeneration (Ophthalmology) pipeline landscape. Age related macular degeneration is the most common reason for vision loss in people aged above 50. It results in depreciation of the macula that may lead to distorted or blurry central vision. The predisposing factors involved are age, smokin......
  • Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 164
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2017, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline landscape. Retinitis Pigmentosa (RP) refers to a group of diseases which cause a slow but progressive vision loss. Retinitis pigmentosa is caused by a genetic defect. Symptoms include night blindness and loss of peripheral vision. The predisposing factor......
  • Presbyopia - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 32
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia - Pipeline Review, H2 2017, provides an overview of the Presbyopia (Ophthalmology) pipeline landscape. Presbyopia is an eye condition in which eye slowly loses the ability to focus quickly on objects that are close. Presbyopia happens in people as they age. Signs and symptoms include headaches, eyestrain, difficulty reading small print and fatigue. Risk factors include anemia, diabetes, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs